Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Wiese

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
International Journal of Clinical Pharmacy|November 19, 2013
Benefits of deprescribing on patients' adherence to medicationsEmily Reeve, Michael D Wiese
Journal of Evaluation in Clinical Practice|September 22, 2016
Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapyNasir Wabe, Michael D Wiese
Drugs & Aging|November 10, 2012
Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderlyEmily Reeve, Michael D Wiese
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2014
Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicineMichael D Wiese, Vijayaprakash Suppiah, Catherine O'Doherty
Pharmacogenomics|June 5, 2014
Cost-effectiveness of genotyping to guide treatmentMichael J Sorich, Michael D Wiese, Brita Pekarsky
Pharmacological Research|September 18, 2021
A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritisDala N Daraghmeh, Catherine King, Michael D Wiese
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Expert Opinion on Drug Metabolism & Toxicology|January 21, 2015
Alterations in drug disposition in older adultsEmily Reeve, Michael D Wiese, Arduino A Mangoni
Thrombosis and Haemostasis|May 4, 2012
Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleedingMichael J Sorich, Thomas M Polasek, Michael D Wiese
Expert Opinion on Investigational Drugs|April 8, 2020
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritisMichael D Wiese, Arkady T Manning-Bennett, Ahmad Y Abuhelwa
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Clinical Pharmacy|November 19, 2013
Benefits of deprescribing on patients' adherence to medicationsEmily Reeve, Michael D Wiese
Journal of Evaluation in Clinical Practice|September 22, 2016
Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapyNasir Wabe, Michael D Wiese
Drugs & Aging|November 10, 2012
Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderlyEmily Reeve, Michael D Wiese
Expert Opinion on Drug Metabolism & Toxicology|June 10, 2014
Metabolic and safety issues for multiple sclerosis pharmacotherapy--opportunities for personalised medicineMichael D Wiese, Vijayaprakash Suppiah, Catherine O'Doherty
Pharmacogenomics|June 5, 2014
Cost-effectiveness of genotyping to guide treatmentMichael J Sorich, Michael D Wiese, Brita Pekarsky
Pharmacological Research|September 18, 2021
A review of liquid biopsy as a tool to assess epigenetic, cfDNA and miRNA variability as methotrexate response predictors in patients with rheumatoid arthritisDala N Daraghmeh, Catherine King, Michael D Wiese
Therapeutic Advances in Drug Safety|August 2, 2014
Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomesMichael J Sorich, Andrew Rowland, Michael D Wiese
Expert Opinion on Drug Metabolism & Toxicology|January 21, 2015
Alterations in drug disposition in older adultsEmily Reeve, Michael D Wiese, Arduino A Mangoni
Thrombosis and Haemostasis|May 4, 2012
Systematic review and meta-analysis of the association between cytochrome P450 2C19 genotype and bleedingMichael J Sorich, Thomas M Polasek, Michael D Wiese
Expert Opinion on Investigational Drugs|April 8, 2020
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritisMichael D Wiese, Arkady T Manning-Bennett, Ahmad Y Abuhelwa
Pageof 16